Skip to main content
. 2020 Nov 22;21(22):8833. doi: 10.3390/ijms21228833

Table 4.

Correlation of miR-1-3p expression with clinicopathological characteristics of 453 lung cancer patients.

Variables miR-1-3p (n = 453)
No. (%) Mean ± SD Median p-Value
Pathology stage
I 248 (54.7) 13.24 ± 18.01 8.07 0.325 a
II 115 (25.4) 10.18 ± 12.27 5.19
III 73 (16.1) 10.88 ± 10.13 6.49
IV 17 (3.8) 12.71 ± 20.41 6.13
pT stage
T1 157 (34.7) 15.18 ± 16.56 e 10.01 0.002 b
T2 238 (52.5) 10.02 ± 15.63 e 5.95
T3 43 (9.5) 12.68 ± 13.92 6.55
T4 15 (3.3) 10.20 ± 7.87 6.61
pN stage
N0 306 (67.5) 12.53 ± 17.29 6.74 0.772 a
N1 81 (17.9) 11.46 ± 13.12 7.67
N2 65 (14.3) 10.80 ± 10.48 6.49
N3 1 (0.3) 3.03 ± 3.03
pM stage
M0 436 (96.2) 12.04 ± 15.58 6.74 0.863 c
M1 17 (3.8) 12.71 ± 20.41 6.13

ap-value were estimated by one-way ANOVA test. bp-values were estimated by Kruskal-Wallis 1-way ANOVA test. cp-value were estimated by Student’s t test, e p < 0.001.